Lipid-Protamine-DNA-Mediated Antigen Delivery

Author(s): Dileep P. Vangasseri, Su-Ji Han, Leaf Huang

Journal Name: Current Drug Delivery

Volume 2 , Issue 4 , 2005

Become EABM
Become Reviewer
Call for Editor


The development of novel new generation vaccine systems that is based on proteins, peptides or DNA is of great current interest. However, due to the lower efficiencies of these new generation vaccines, they are seldomly used alone. Rather, their formulations often contain adjuvants, either to enhance the immune responses or to reduce dosing. The present chapter will provide a brief overview of the recent advances in peptide-based cancer vaccine adjuvants, focusing mainly on Liposome-Protamine-DNA (LPD) nanoparticle-mediated antigen delivery.

Keywords: immunogens, cancer vaccines, peptide antigen, mhc molecule, antigen presenting cells (apc), anti-tumor

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [401 - 406]
Pages: 6
DOI: 10.2174/156720105774370168
Price: $65

Article Metrics

PDF: 5